Piscataway, NJ--11 June--The journal Science and Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), today announced a call for applicants for the 2002 Amersham ...

Amersham, the biggest maker of diagnostic imaging products, plans to pay about $1billion in cash for Pharmacia Corp.' Amersham to Buy Rest of Biosciences Venture - Los Angeles Times ...

Home; Archive; December 2002; Cell Screening Goes High Throughput Photo: Courtesy of Amersham Biosciences AMERSHAM BIOSCIENCE's IN Cell Analyzer system Drug discovery frequently involves the screening ...

Amersham Biosciences, a leading global provider of integrated systems and solutions for disease research and drug development, joined with Science to establish the Young Scientist Prize in 1995.

BIOTECH group Amersham is to buy out the remaining 45% in Amersham Biosciences from US-owned Pharmacia Corporation for £704m in cash. The long-predicted move will give Amersham complete control ...

Automating 2-D Gel Electrophoresis Courtesy of Amersham Biosciences Amersham Biosciences www.amershambiosciences.com The Ettan™ proteomics product line includes the Ettan IPGphor™ IEF system and Ettan ...

BIOTECH group Amersham is to buy out the remaining 45% in Amersham Biosciences from US-owned Pharmacia Corporation for £704m in cash. The long-predicted move will give Amersham complete control ...

Amersham plc announces that it has reached an agreement in principle to purchase Pharmacia Corporation?s 45 per cent shareholding in Amersham Biosciences, taking Amersham?s ownership of the ...

Epoch Biosciences Inc. of Bothell said Tuesday it has inked a distribution deal with Amersham Biosciences to market and sell Epoch's MGB Eclipse Probe Systems to genetic analysis researchers ...

LONDON -- Amersham PLC Tuesday said it agreed to buy the 45% stake in Amersham Biosciences it doesn't own from U.S.-based Pharmacia Corp. for $1 billion and said it has abandoned plans to float ...